Bio-Techne
TECH
#2238
Rank
A$12.39 B
Marketcap
A$79.18
Share price
-0.25%
Change (1 day)
0.01%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): A$1.05

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$1.00. In 2025 the company made an earnings per share (EPS) of A$0.73 a decrease over its 2024 EPS that were of A$1.41.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.0542.35%
2025A$0.73-48%
2024A$1.41-29.58%
2023A$2.01-14.97%
2022A$2.3624.16%
2021A$1.9017.98%
2020A$1.61-10.94%
2019A$1.81101.57%
2018A$0.90-16.99%
2017A$1.0845.02%
2016A$0.75-20.97%
2015A$0.94-14.97%
2014A$1.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.75 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$7.72 669.01%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$11.57 1,053.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.33 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.91 190.15%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
A-$0.30-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A$8.63 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA